Though this humanized PBMC mouse model provides co-clinical experimental advantages when compared with humanized CD34+ model, with quick engraftment times and requiring few milliliters of patient blood, it does present with the limitation of graft-versus-host disease (GVHD) onset as a function of enrichment in engrafted human T cells. The gene discussed is CD34; the disease is graft versus host disease.